vs
Arbutus Biopharma Corp（ABUS）与美国运通（AXP）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是Arbutus Biopharma Corp的1760.6倍（$18.9B vs $10.7M），Arbutus Biopharma Corp净利率更高（23.5% vs 15.7%，领先7.8%），Arbutus Biopharma Corp同比增速更快（522.2% vs 11.4%），过去两年美国运通的营收复合增速更高（38.8% vs -13.2%）
Arbutus生物制药是一家公开上市的加拿大生物制药企业，专长于脂质体药物递送与RNA干扰技术，目前主要开展针对乙型肝炎感染的治疗药物研发工作，在抗病毒新药研发领域拥有深厚的技术积累。
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
ABUS vs AXP — 直观对比
营收规模更大
AXP
是对方的1760.6倍
$10.7M
营收增速更快
ABUS
高出510.8%
11.4%
净利率更高
ABUS
高出7.8%
15.7%
两年增速更快
AXP
近两年复合增速
-13.2%
损益表 — Q2 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.7M | $18.9B |
| 净利润 | $2.5M | $3.0B |
| 毛利率 | — | — |
| 营业利润率 | 13.9% | — |
| 净利率 | 23.5% | 15.7% |
| 营收同比 | 522.2% | 11.4% |
| 净利润同比 | 112.7% | 15.0% |
| 每股收益（稀释后） | $0.01 | $4.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABUSAXP
| Q1 26 | — | $18.9B | ||
| Q4 25 | — | $10.9B | ||
| Q3 25 | — | $10.4B | ||
| Q2 25 | $10.7M | $10.3B | ||
| Q1 25 | — | $9.6B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $9.7B | ||
| Q2 24 | — | $9.8B |
净利润ABUSAXP
| Q1 26 | — | $3.0B | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $2.5M | $2.9B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $3.0B |
营业利润率ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 28.2% | ||
| Q3 25 | — | 36.7% | ||
| Q2 25 | 13.9% | 34.4% | ||
| Q1 25 | — | 34.6% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | — | 33.0% | ||
| Q2 24 | — | 38.6% |
净利率ABUSAXP
| Q1 26 | — | 15.7% | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | 23.5% | 28.0% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 21.8% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 30.7% |
每股收益（稀释后）ABUSAXP
| Q1 26 | — | $4.28 | ||
| Q4 25 | — | $3.52 | ||
| Q3 25 | — | $4.14 | ||
| Q2 25 | $0.01 | $4.08 | ||
| Q1 25 | — | $3.64 | ||
| Q4 24 | — | $3.04 | ||
| Q3 24 | — | $3.49 | ||
| Q2 24 | — | $4.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | — |
| 总债务越低越好 | $0 | $60.4M |
| 股东权益账面价值 | $83.0M | $34.0M |
| 总资产 | $103.3M | $308.9M |
| 负债/权益比越低杠杆越低 | 0.00× | 1.78× |
8季度趋势，按日历期对齐
现金及短期投资ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $742.0M | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $37.4M | $197.0M | ||
| Q1 25 | — | $261.0M | ||
| Q4 24 | — | $221.0M | ||
| Q3 24 | — | $120.0M | ||
| Q2 24 | — | $188.0M |
总债务ABUSAXP
| Q1 26 | — | $60.4M | ||
| Q4 25 | — | $56.4B | ||
| Q3 25 | — | $57.8B | ||
| Q2 25 | $0 | $58.2B | ||
| Q1 25 | — | $51.2B | ||
| Q4 24 | — | $49.7B | ||
| Q3 24 | — | $53.5B | ||
| Q2 24 | — | $51.5B |
股东权益ABUSAXP
| Q1 26 | — | $34.0M | ||
| Q4 25 | — | $33.5B | ||
| Q3 25 | — | $32.4B | ||
| Q2 25 | $83.0M | $32.3B | ||
| Q1 25 | — | $31.2B | ||
| Q4 24 | — | $30.3B | ||
| Q3 24 | — | $29.7B | ||
| Q2 24 | — | $29.5B |
总资产ABUSAXP
| Q1 26 | — | $308.9M | ||
| Q4 25 | — | $300.1B | ||
| Q3 25 | — | $297.6B | ||
| Q2 25 | $103.3M | $295.6B | ||
| Q1 25 | — | $282.2B | ||
| Q4 24 | — | $271.5B | ||
| Q3 24 | — | $271.0B | ||
| Q2 24 | — | $272.2B |
负债/权益比ABUSAXP
| Q1 26 | — | 1.78× | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | 0.00× | 1.80× | ||
| Q1 25 | — | 1.64× | ||
| Q4 24 | — | 1.64× | ||
| Q3 24 | — | 1.80× | ||
| Q2 24 | — | 1.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.7M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -6.24× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $6.2B | ||
| Q2 25 | $-15.7M | $4.4B | ||
| Q1 25 | — | $4.8B | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | $-1.8B | ||
| Q2 24 | — | $4.5B |
自由现金流ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $5.6B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $-2.3B | ||
| Q2 24 | — | $4.0B |
自由现金流率ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 45.0% | ||
| Q4 24 | — | 53.1% | ||
| Q3 24 | — | -23.3% | ||
| Q2 24 | — | 40.4% |
资本支出强度ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | — | 5.8% |
现金转化率ABUSAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 2.15× | ||
| Q2 25 | -6.24× | 1.51× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | 2.66× | ||
| Q3 24 | — | -0.72× | ||
| Q2 24 | — | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
